Biotech Firm Vir Scored Big with Monoclonal Antibodies in the Pandemic's Early Days. Now ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Biotech firm Vir scored big with monoclonal antibodies in the pandemic’s early days. Now it needs to look beyond Covid ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)